Healthcare
Rebus Holdings, Inc.(RBSH)
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 โ Jun 9, 2026
- Market Cap
- โ
- Revenue Growth
- 0.0%
- EPS Growth
- -109.2%
- Dividend Yield
- 0.0%
Coverage: 243 bars ยท Jun 23, 2025 โ Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Rebus Holdings, Inc. (RBSH) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 โ Jun 9, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -109.2%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -109.2%, free cash flow -1.9% with operating margin 0.0% and ROIC 13.5%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines RBSH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2023 was reported on Jun 30, 2023, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at 0.0% and EPS is at -109.2%, with operating margin around 0.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2023 Jun 30, 2023 | โ | +0.0% | +0.0% | +0.0% |
2023 Mar 31, 2023 | โ | +0.0% | +0.0% | +0.0% |
2022 Dec 31, 2022 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RBSH
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
RBSH Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RBSH and SPY.
Company Overview
Rebus Holdings, Inc.
Other OTC
Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.
- Leadership
- Raul Silvestre
- IPO Date
- Nov 4, 2009
- Employees
- 1
- Street Address
- 2629 Townsgate Road
- Mailing
- Westlake Village, CA, 91361
- Region
- Westlake Village, CA, US
- Reporting Currency
- USD
- Investor Line
- 818 597 7552
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- โ
- Price/Book
- โ
Growth
- Revenue
- 0.0%
- EPS
- -109.2%
- Free Cash Flow
- -1.9%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- 19.9%
- ROIC
- 13.5%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.00
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.